Where & When
Saturday, September 27, 2025
Detroit Marriott Troy
200 W Big Beaver Rd.
Troy, MI 48084
Breakfast and registration opens 7:00 a.m.
Download the flyer
Registration
Online registration is now closed. We will ONLY be accepting on-site registration. Registration opens Saturday, Sept. 27 at 7:00 a.m. Please contact Pam Sydorchuk, Symposium coordinator, at 313-576-8746 if you have any questions.
Program Director
Hirva Mamdani, M.D.
Accreditation
This activity has been approved for up to 5.50 AMA PRA Category 1 Credit™
Provided by Wayne State University School of Medicine and Karmanos Cancer Institute.
Agenda
7 - 8 a.m.
Registration & Breakfast
8:00 - 8:10 a.m.
Welcoming Remarks
Hirva Mamdani, M.D., Program Director
8:10 - 8:30 a.m.
Lung Cancer Screening in 2025
Amina Pervaiz, M.D.
Karmanos Cancer Institute, Wayne State University
8:30 - 8:55 a.m.
Perioperative Immunotherapy for Resectable NSCLC
Guest Speaker: Ryan Gentzler, M.D.
University of Virginia
8:55 - 9:20 a.m.
Perioperative Targeted Therapy for Resectable NSCLC
Guest Speaker: Antoinette Wozniak, M.D.
Lung Cancer Research Foundation
9:20 - 9:45 a.m.
Locally Advanced Unresectable NSCLC: Current Approach and Future Directions
Dipesh Uprety, M.D. FACP
Karmanos Cancer Institute/Wayne State University
9:45 - 10:15
Case Presentations and Panel Discussion
Presenter: Khalil Choucair, M.D., MSc
Karmanos Cancer Institute, Wayne State University
Moderator: Hirva Mamdani, M.D.
10:15 - 10:35 a.m.
Break
10:35 - 11:00 a.m.
Small Cell Lung Cancer: Treatment Breakthroughs and Challenges
Guest Speaker: Meera Patel, M.D.
Baylor College of Medicine
11:00 - 11:25 a.m.
Treatment of Advanced NSCLC harboring EGFR Mutation
Guest Speaker: Elliott J. Brea, M.D., Ph.D.
Dana Farber Cancer Institute
11:25 - 11:50 a.m.
Treatment of Advanced NSCLC without Actionable Genomic Alterations
Guest Speaker: Saiama Waqar, M.D. MSCI
Washington University School of Medicine
11:50 a.m. - 12:30 p.m.
Lunch
12:30 - 12:55 p.m.
Updates in the Treatment of Advanced NSCLC Harboring ALK, ROS-1, and MET Alterations
Khalil Choucair, M.D., MSc
Karmanos Cancer Institute, Wayne State University
12:55 - 1:20 p.m.
Updates in the Treatment of Advanced NSCLC Harboring KRAS and HER-2 Alterations
Tarik Hadid, M.D.
Karmanos Cancer Institute, Wayne State University
1:20 - 1:40 p.m.
Shared Decision Making in Oncology
Morhaf Al Achkar, M.D.
Karmanos Cancer Institute, Wayne State University
1:40 - 2:10 p.m.
Case Presentations and Panel Discussion
Presenter: Khalil Choucair, M.D., MSc
Karmanos Cancer Institute, Wayne State University
Moderator: Hirva Mamdani, M.D.
2:10 - 2:15 p.m.
Closing Remarks
Hirva Mamdani, M.D.
More Information
For any additional questions, please contact Pamela Sydorchuk, symposium coordinator, at symposium@karmanos.org or call 313-576-8746.